Bristol Myers Squibb

BMYHealth carePharmaceuticals

$64.19

Close on Nov 4, 2026

$131.2B

What does Bristol Myers Squibb do?

Bristol Myers Squibb makes medicines for cancer, blood clots, immune diseases and mental illness, such as Opdivo and Eliquis.

Revenue by region

Fiscal year 2025

United States69.1%
International28.7%
Other Region2.3%

As reported in the company's annual report (10-K).

Stock price

Useful context, but not the main focus.

+40.8% over the past year

Drag across the chart to compare two days.Touch the chart with two fingers to compare two days.

Key financial information

What it is · Why it matters · How to read it in context.

Fiscal year 2025, ended December 2025 · U.S. dollarsClick any metric to see what it means.

$48.2B
Previous year:
$48.3B
−0.2%
Previous year:
+7.3%
+7.1%
$7.05B
Previous year:
−$8.95B
14.6%
Previous year:
−18.5%
13.0%
$12.8B
Positive in each of the last 5 years
$12.6B/$43.6B
Cash22%
$12.6B
Debt78%
$43.6B
As of Sep 30, 2026
14.2
Last 12 months
17.8
32.1
3.9%
Paid over the last 12 months: $2.52 per share

5-year trends

Annual figures, fiscal years 2021-2025.

Financial figures come from company filings with the U.S. Securities and Exchange Commission (SEC). Latest filing used: October 29, 2026. Stock prices are end-of-day closing prices.